SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001714899-24-000087
Filing Date
2024-02-28
Accepted
2024-02-27 20:21:24
Documents
5
Effectiveness Date
2024-02-28

Document Format Files

Seq Description Document Type Size
1 S-8 forms-82024.htm S-8 79305
2 EX-FILING FEES s-8ex1071filingfeetable2024.htm EX-FILING FEES 19228
3 EX-5.1 s-8exhibit512024.htm EX-5.1 8239
4 EX-23.1 s-8exhibit2312024.htm EX-23.1 2392
5 image_1.jpg GRAPHIC 365942
  Complete submission text file 0001714899-24-000087.txt   604524
Mailing Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filer) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277429 | Film No.: 24689650
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)